Ledger.Open graph →
SEC Form D · Amendment · filed May 28, 2015

Compass Therapeutics LLC

Offering
$1.0M
Sold
$575K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HANOVER, NH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Errik Anderson · HANOVER, NHExec · DirectorSteve Tregay · HANOVER, NHDirectorJulien Lagreze · PARIS, I0DirectorJay Yook · LOS ANGELES, CAExec · DirectorSchuetz Thomas · Hanover, NHExec · DirectorJennifer Carolan · Palo Alto, CAExec · DirectorJames E. Wiggins · Columbus, OHDirectorSchuetz Thomas · Hanover, NHExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗